Blood Cancer Talks

This podcast on the management of blood cancers and hematology is hosted by Raj Chakraborty, MD; Ashwin Kishtagari, MD; and Edward Cliff, MD.

Articles by Blood Cancer Talks

Blood Cancer TalksBlood Cancer Talks | November 21, 2024
The group discussed four abstracts on belantamab mafodotin in MM presented at EHA 2024 and ASCO 2024.
Blood Cancer TalksBlood Cancer Talks | November 14, 2024
Andrew Evens, DO, MSc, FACP, discusses tailoring management by patient fitness in this setting plus recent clinical trials.
Blood Cancer TalksBlood Cancer Talks | November 13, 2024
On this episode, Andrew Wei, MBBS, PhD, goes especially in depth regarding venetoclax plus azacitidine combination.
Blood Cancer TalksBlood Cancer Talks | September 5, 2024
“Blood Cancer Talks" hosts are joined by Timothy Schmidt, MD, to discuss quadruplet therapy for myeloma.
Blood Cancer TalksBlood Cancer Talks | September 5, 2024
“Blood Cancer Talks" hosts are joined by Dr. Stahl to discuss imetelstat and luspatercept treatment for lower-risk MDS.
Blood Cancer TalksMyeloma | May 30, 2024
Drs. Hira Mian and Manni Mohyuddin join the hosts of "Blood Cancer Talks" for an overview of myeloma maintenance therapy.
Blood Cancer TalksBlood Cancer Talks | April 18, 2024
Raajit Rampal, MD, PhD, and the "Blood Cancer Talks" hosts discuss the diagnosis and management of essential thrombocythemia.
Blood Cancer TalksMyeloma | March 29, 2024
KarMMa-3 trial evaluated ide-cel in MM, while the CARTITUDE-4 trial evaluated cilta-cel in MM.
Blood Cancer TalksBlood Cancer Talks | July 30, 2024
Dr. Tefferi discussed choosing the right mentors, balancing the clinical and the research, and becoming a "master physician."
Blood Cancer TalksBlood Cancer Talks | February 27, 2024
Dr. Dispenzieri, of the Mayo Clinic, joins the "Blood Cancer Talks" hosts to discuss how to treat and manage AL amyloidosis.
Blood Cancer TalksAcute Myeloid Leukemia | March 4, 2024
Dr. Patel and the hosts discuss the TRANSFORM-1 study, MANIFEST-2, AUGMENT-101, and more.
Blood Cancer TalksBlood Cancer Talks | March 20, 2024
Dr. Eyre and the hosts discuss lymphoma abstracts from ASH 2023, including the FLAIR trial and the SYMPATICO trial.
Blood Cancer TalksBlood Cancer Talks | January 24, 2024
Shernan Holtan, MD, and the hosts discuss recent data on graft versus host disease prophylaxis.
Blood Cancer TalksBlood Cancer Talks | January 10, 2024
Dr. Derman and the hosts discuss myeloma abstracts from ASH 2023, including the PERSEUS trial and the KarMMa-3 trial.
Blood Cancer TalksBlood Cancer Talks | December 5, 2023
Dr. Dickinson joins "Blood Cancer Talks" hosts to discuss phase I and II trials on DLBCL, follicular lymphoma, and more.
Blood Cancer TalksBlood Cancer Talks | December 6, 2023
Alexander Perl, MD, joins the hosts to discuss the management of newly diagnosed and relapsed FLT3-positive AML.
Blood Cancer TalksBlood Cancer Talks | November 22, 2023
The episode also discusses Dr. Raza's book, "The First Cell," which recounts stories of her patients with terminal cancer.
Blood Cancer TalksBlood Cancer Talks | October 19, 2023
Kate Cwynarski, MBBS, PhD, of the University of College London, discusses the management of CNS lymphomas.
Blood Cancer TalksBlood Cancer Talks | October 20, 2023
This episode of "Blood Cancer Talks" discusses the biology and management of multiple myeloma and the role of venetoclax.
Blood Cancer TalksBlood Cancer Talks | October 18, 2023
The episode also highlights the S1211 study, which is the first randomized controlled trial with high-risk enrichment in MM.